Safety assurance for automated systems in transport: A collective case study of real-world fatal crashes

被引:0
|
作者
Ballingall, Stuart [1 ]
Sarvi, Majid [1 ]
Sweatman, Peter [1 ]
机构
[1] Univ Melbourne, Dept Infrastruct Engn, Grattan St, Parkville, Vic 3010, Australia
关键词
Automated Driving Systems; Safety assurance; Case study; Vehicle safety; Autonomous vehicles;
D O I
10.1016/j.jsr.2024.11.008
中图分类号
TB18 [人体工程学];
学科分类号
1201 ;
摘要
Introduction: Traditional vehicle safety assurance frameworks are challenged by Automated Driving Systems (ADSs) that enable dynamic driving tasks to be performed without active involvement of a human driver. Further, an ADS's driving functionality can be changed during in-service operation, using software updates developed using Machine Learning (ML). Learnings from real-world cases will be a key input to reforming current regulatory frameworks to assure ADS safety. However, ADSs are yet to be deployed in mass volumes, and limited data are available regarding their in-service safety performance. Method: To overcome these limitations, a collective case study was undertaken, drawing upon three relevant real-world cases involving automated control systems that were a causative factor in major transport safety incidents. Results: A range of findings were identified, which informed recommendations for reform. The study found some assurance processes, decisions and oversight were not commensurate with risk or safety integrity levels, including a lack of independence with reviews and approvals for safety-critical system components. Two cases were also impacted by conflict or bias with regulatory approvals. Other commonalities included a lack of safeguards to ensure systems were not operated outside their design domain, and a lack of system redundancy to ensure safe operation if a system component fails. Further, the identification and validation of system responses to scenarios that could be encountered within design domain boundaries was lacking. For the two cases in which safety-critical functionality was developed using ML, it's concerning no regulator reports provided detailed findings regarding the role of ML models, algorithms, or training data.
引用
收藏
页码:27 / 39
页数:13
相关论文
共 50 条
  • [21] Design and implementation of emulators for a real-world automated manufacturing systems using scenario
    Huang, YS
    Chung, TH
    Wen, YL
    PROGRESS ON ADVANCED MANUFACTURE FOR MICRO/NANO TECHNOLOGY 2005, PT 1 AND 2, 2006, 505-507 : 1141 - 1146
  • [22] Last-mile delivery by automated droids. Sustainability assessment on a real-world case study
    Garus, Ada
    Alonso, Borja
    Raposo, Maria Alonso
    Grosso, Monica
    Krause, Jette
    Mourtzouchou, Andromachi
    Ciuffo, Biagio
    SUSTAINABLE CITIES AND SOCIETY, 2022, 79
  • [23] Mechanisms of Head and Neck Injuries Sustained by Helmeted Motorcyclists in Fatal Real-World Crashes: Analysis of 47 In-Depth Cases
    Whyte, Thomas
    Gibson, Tom
    Anderson, Robert
    Eager, David
    Milthorpe, Bruce
    JOURNAL OF NEUROTRAUMA, 2016, 33 (19) : 1802 - 1807
  • [24] Prediction of lower extremity injuries in car-pedestrian crashes - real-world accident study
    Panday, Pushpender
    Vikram, Aman
    Chawla, Anoop
    Mukherjee, Sudipto
    TRAFFIC INJURY PREVENTION, 2021, 22 (02) : 173 - 176
  • [25] Reset to Zero and Specify Active Safety Systems according to Real-World Needs
    Gkikas, Nikolaos
    Hill, Julian R.
    Richardson, John H.
    JOURNAL OF TRANSPORTATION ENGINEERING-ASCE, 2010, 136 (05): : 465 - 471
  • [26] Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database
    Wu, Junlin
    Wu, Hanbiao
    Chen, Lili
    Liang, Haiping
    Huang, Guoning
    Yang, Sensen
    Chen, Bishan
    Noguchi, Yoshihiro
    Shen, Yonggang
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (07) : 905 - 916
  • [27] Efficacy and safety of apatinib in treatment of unresectablehepatocellular carcinoma: A real-world study
    Liu, Jun
    Li, Guangbing
    He, Qiang
    Sun, Shijun
    Zhao, Chuanlin
    Sun, Chuandong
    Zhang, Bo
    Cui, Yi
    Ye, Yongqiang
    Zhi, Xuting
    Li, Shiping
    Pan, Guozheng
    Ma, Changlin
    Hu, Jinhua
    Li, Jun
    Wang, Suling
    Qiao, Yuangang
    Ren, Wanhua
    Meng, Qi
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
    Sun, Yu
    Xu, Tao
    Xu, Hongbin
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [29] REAL-WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD IN ULCERATIVE COLITIS: A MULTICENTER STUDY
    Lieto, Stephen
    Scalzo, Nicholas
    Huang, Katherine
    Khan, Abdul
    Xu, Anthony
    Pekow, Joel
    Rajauria, Palak
    Ayoub, Malek
    Johnson, Amanda M.
    Yarur, Andres
    Patel, Anish
    Bishu, Shrinivas
    Shukla, Richa
    Osterman, Mark T.
    Paul, Damemarie
    Sokol, Uyen
    Tharmarajah, Soba
    Lawlor, Garrett
    Ahmad, Harris
    Rubin, David T.
    Sands, Bruce E.
    Deepak, Parakkal
    Ungaro, Ryan C.
    GASTROENTEROLOGY, 2024, 166 (05) : S1455 - S1456
  • [30] Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study
    Bodmann, Klaus-Friedrich
    Hagel, Stefan
    Oliva, Alessandra
    Kluge, Stefan
    Mularoni, Alessandra
    Galfo, Valentina
    Falcone, Marco
    Pletz, Mathias W.
    Lindau, Simone
    Kaeding, Nadja
    Kielstein, Jan T.
    Zoller, Michael
    Tascini, Carlo
    Kintrup, Sebastian
    Schaedler, Dirk
    Spies, Claudia
    De Rosa, Francesco G.
    Radnoti, Szilvia
    Bandera, Alessandra
    Luzzati, Roberto
    Allen, Sam
    Sarmati, Loredana
    Cascio, Antonio
    Kapravelos, Nikolaos
    Subudhi, Chinari P. K.
    Dimopoulos, George
    Vossen, Matthias G.
    Bal, Abhijit M.
    Venditti, Mario
    Mastroianni, Claudio M.
    Borrmann, Thomas
    Mayer, Christian
    INFECTIOUS DISEASES AND THERAPY, 2025, : 765 - 791